Cognis’ botanicals extracts business, which operates two production sites in Spain, generated sales of approximately €9 million in 2007. Its main products are liquorice derivatives, phytopharmaceuticals, and dry and liquid herbal extracts for dietary supplements and cosmetic industries. Under the terms of the agreement, Cognis will continue production and distribution of certain botanical products for the cosmetics industry and will retain ownership of its Plantalin range, which is comprised of selective plant extracts designed for functional food and beverage applications.
Burgundy Botanical Extracts will distribute the Plantalin range to the pharmaceuticals and dietary supplements industry in the EU.
“We are very pleased about this agreement with Burgundy. With its market strength, the company will leverage the key synergies and realize the growth potential that this unique combination will offer to the market,” said Stéphane Baseden, executive vice president nutrition and health, Cognis. “We will work closely together with Burgundy to ensure a smooth transition of the business operations.”
More info: www.cognis.com